Lucentis

Regeneron's Eylea works better vs Avastin and Lucentis in study
Yahoo/Reuters
Fri, 10/17/14 - 09:50 am
Regeneron
Eylea
Avastin
Lucentis
diabetic macular edema
FDA accepts sBLA for Lucentis label expansion
Seeking Alpha
Wed, 10/8/14 - 01:06 pm
FDA
Lucentis
Roche
Genentech
diabetic retinopathy
New use for Bayer's Eylea in EU gives it more market power against Novartis' Lucentis
Fierce Pharma
Mon, 08/11/14 - 11:51 am
Europe
Novartis
Lucentis
Eylea
Bayer
Genentech Submits sBLA for Diabetic Retinopathy Drug
Drug Discovery and Development
Fri, 08/8/14 - 05:08 pm
Genentech
Roche
diabetic retinopathy
Lucentis
Using Avastin for Eye Disorder Could Save U.S. $3 Billion
Bloomberg
Mon, 06/2/14 - 06:13 pm
Avastin
Roche
Lucentis
age-related macular degeneration
diabetic macular edema
Italy to seek $1.6 billion damages from Roche, Novartis
Marketwatch
Thu, 05/29/14 - 01:14 pm
Italy
Roche
Novartis
antitrust
Lucentis
Tale of two eye drugs plays out in Medicare's doctor reimbursements
Tampa Bay News, FL
Wed, 04/16/14 - 10:43 am
Medicare
physicians
off-label
Lucentis
Avastin
PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative
Seeking Alpha
Tue, 02/4/14 - 09:58 am
PDL Biopharma
Roche
Genentech
Avastin
Herceptin
Lucentis Xolair
Kadcyla
Perjeta
Lucentis
PDL Biopharma says it settled Roche royalty fight
Yahoo/AP
Mon, 02/3/14 - 03:58 pm
PDL Biopharma
Roche
Avastin
Herceptin
Kadcyla
Perjeta
Lucentis
Xolair
Bayer's hot-selling Eylea runs into a roadblock in its home market
Fierce Pharma
Sat, 01/4/14 - 04:32 pm
Eylea
Bayer
Novartis
macular edema
Lucentis
Germany
Novartis reports new data for Lucentis backs transformational efficacy
The Fly on the Wall
Fri, 09/27/13 - 08:59 am
Novartis
Lucentis
Should You Keep an Eye on These Eye Treatment Biotechs?
Motley Fool
Fri, 08/9/13 - 10:30 am
wet age-related macular degeneration
diabetic macular edema
Lucentis
Novartis
Roche
Eylea
Regeneron
Optina
Ampio Pharmaceuticals
Regeneron Shareholders Watching Optina Trial Closely
Seeking Alpha
Thu, 05/23/13 - 11:32 am
Optina
Regeneron
Novartis
Eylea
Ampio Pharmaceuticals
age-related macular degeneration
Lucentis
Italian antitrust agency probes alleged Roche-Novartis cartel
Fierce Pharma
Wed, 02/20/13 - 12:12 pm
Lucentis
Roche
Avastin
Italy
Novartis
antitrust
Novartis’s Lucentis Wins U.K. Backing as Drug’s Price Cut
Bloomberg
Thu, 01/3/13 - 11:35 am
UK
Novartis
Lucentis
diabetic macular edema
1 Pharma Receiving Nice News (NVS)
Motley Fool
Wed, 10/10/12 - 11:16 am
NICE
Novartis
Lucentis
DME
diabetic macular edema
NICE reverses position on new use for Novartis' Lucentis
Fierce Pharma
Fri, 10/5/12 - 12:27 pm
NICE
UK
Novartis
Lucentis
diabetic macular edema
FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
Pipeline Review
Sat, 08/11/12 - 12:57 pm
Lucentis
Genentech
Roche
diabetic macular edema
Roche’s Lucentis Works To Treat Vision Loss From Diabetes
Bloomberg
Tue, 07/24/12 - 11:19 am
Roche
diabetes
Lucentis
vision loss
diabetic macular edema
Vivus, Onyx, Amarin Await Key Dates in July
Minyanville
Tue, 07/3/12 - 11:43 am
Amarin
ONYX Pharmaceuticals
Vivus
Qnexa
AMR101
Arcalyst
Regeneron
Kyprolis
Salix
Relistor
Progenics Pharmaceuticals
Rayos
Roche
Lucentis
Horizon Pharma

Pages